Skip to main content

. 1982 Jan 16;284(6310):161–162. doi: 10.1136/bmj.284.6310.161

Alveolitis after treatment with amiodarone.

S A Riley, S E Williams, N J Cooke

PMCID: PMC1495560 PMID: 6799079

Images in this article

p161-a
on p.161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

D'Amico D. J., Kenyon K. R., Ruskin J. N. Amiodarone keratopathy: drug-induced lipid storage disease. Arch Ophthalmol. 1981 Feb;99(2):257–261. doi: 10.1001/archopht.1981.03930010259007. [DOI] [PubMed] [Google Scholar]
Marcus F. I., Fontaine G. H., Frank R., Grosgogeat Y. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am Heart J. 1981 Apr;101(4):480–493. doi: 10.1016/0002-8703(81)90140-x. [DOI] [PubMed] [Google Scholar]
Rees A., Dalal J. J., Reid P. G., Henderson A. H., Lewis M. J. Dangers of amiodarone and anticoagulant treatment. Br Med J (Clin Res Ed) 1981 May 30;282(6278):1756–1757. doi: 10.1136/bmj.282.6278.1756-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rotmensch H. H., Liron M., Tupilski M., Laniado S. Possible association of pneumonitis with amiodarone therapy. Am Heart J. 1980 Sep;100(3):412–413. doi: 10.1016/0002-8703(80)90165-9. [DOI] [PubMed] [Google Scholar]
Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES